Tag: anti-thyroid drugs market analysis

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Anti-Thyroid Drugs Market Expected To Expand Between 2025 And 2029?

The anti-thyroid drugs market size has seen modest growth in recent years. This market is projected to expand from $2.46 billion in 2024 to $2.49 billion by 2025, reflecting a compound annual growth rate (CAGR) of 1.2%. The historical increase in the market can be attributed to the prevalence of thyroid disorders, advancements in drug development, and improvements in healthcare infrastructure.

The anti-thyroid drugs market size is projected to experience consistent expansion over the upcoming years. By 2029, this market is anticipated to reach $2.76 billion, exhibiting a compound annual growth rate (CAGR) of 2.6%. Several factors are expected to drive this growth during the forecast period, including increased patient awareness and education, rising healthcare expenditure, evolving patient demographics, and prevailing global economic conditions. Key trends identified for the forecast period encompass alternatives to thyroid surgery and radioactive iodine, a shift towards patient-centric care, and the integration of telemedicine and remote monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Major Market Drivers Are Shaping The Future Of The Anti-Thyroid Drugs Market?

Graves’ disease is a direct contributor to hyperthyroidism, and its incidence is on the rise. According to the National Library of Medicine, a US-based biomedical library operated by the United States federal government, Graves’ disease (GD) is the most frequent cause of hyperthyroidism in developed countries. It primarily affects individuals between 30 and 60 years of age, and women are 5–10 times more prone to it than men. Genetic predisposition accounts for 79% of the risk for GD, while environmental factors are responsible for 21%. Due to the increasing number of Graves’ disease cases, the population suffering from hyperthyroidism is also expanding. This trend subsequently leads to an overall increase in the demand for anti-thyroid drugs, thereby driving the market forward.

What Are The Leading Segments Analyzed In The Anti-Thyroid Drugs Market?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

How Are Trends Influencing The Anti-Thyroid Drugs Market?

Associations for thyroid care are launching initiatives to broaden understanding of thyroid disorders, share recent treatment advancements, and provide overviews of various research conducted on thyroid conditions. A concerning issue is that in the USA, nearly 60% of the population with hyperthyroidism is unaware and goes undiagnosed. To mitigate these problems, organizations like the American Thyroid Association (ATA) are actively educating people about thyroid disorders. Similarly, the Thyroid Foundation of Canada has also undertaken awareness campaigns to engage public interest and knowledge about thyroid diseases, including hyperthyroidism. Other groups initiating awareness programs include the American Academy of Otolaryngology and the British Thyroid Foundation, among others.

Which Major Industry Participants Are Leading The Anti-Thyroid Drugs Market Growth?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Geographies Are Emerging As Strong Markets For The Anti-Thyroid Drugs Industry?

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Anti-Thyroid Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2025, By The Business Research Company

Diuretics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Anti-Thyroid Drugs Market Today And What Is Its Future Size?

In recent years, the market size for anti-thyroid drugs has seen a slight increase. The market is projected to expand from $2.46 billion in 2024 to $2.49 billion in 2025, experiencing a compound annual growth rate (CAGR) of 1.2%. Factors contributing to this growth during the historic period include the prevalence of thyroid disorders, progress in drug development, and healthcare infrastructure.

The market size for anti-thyroid drugs is set for consistent expansion in the forthcoming years. Projected to surge to “$2.76 billion by 2029”, the market is set to achieve a compound annual growth rate (CAGR) of 2.6%. The predicted growth during the forecast period is due to factors such as increased patient awareness and education, healthcare spending, patient demographics, and the global economic environment. Key trends in this forecast period include alternatives to thyroid surgery and radioactive iodine, a focus on patient-centric care, and the integration of telemedicine and remote monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Anti-Thyroid Drugs Market?

The prevalence of Graves’ disease, a key contributor to hyperthyroidism, is on the rise. The National Library of Medicine, a biomedical repository overseen by the United States Federal Government, suggests that in developed nations, Graves’ disease (GD) is the leading cause of hyperthyroidism. Those aged between 30 and 60 are most susceptible to the disease, with women 5-10 times more prone than men. Factors such as genetic predisposition contribute to 79% of the GD risk while the environment accounts for a 21% risk. The augmentation in cases of Graves’ disease corresponds to an increase in individuals suffering from hyperthyroidism. As a result, the demand for anti-thyroid drugs is escalating, fuelling market growth.

How Is The Anti-Thyroid Drugs Market Categorized Across Applications And Types?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

How Are Market Trends Influencing Competition In The Anti-Thyroid Drugs Market?

Organizations focused on thyroid health are initiating efforts to increase awareness about thyroid conditions, share recent advancements in treatment and relay findings from various thyroid-related research studies. In the USA, an estimated 60% of individuals with hyperthyroidism are not aware of their condition and remain undiagnosed. To address these problems, organizations like the American Thyroid Association (ATA) are playing a pivotal role in educating the populace about thyroid conditions. Likewise, the Thyroid Foundation of Canada is also pioneering public engagement and consciousness increase with regard to thyroid diseases including hyperthyroidism. Other groups, such as the American Academy of Otolaryngology and the British Thyroid Foundation, are also launching their own initiatives and awareness campaigns.

Which Firms Are Making The Biggest Impact In The Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Region Holds The Greatest Opportunity For Anti-Thyroid Drugs Market Expansion?

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Are the Forecasted Growth Rate and Market Size of the Research Antibodies and Reagents Market?#_x000D_

In the recent past, the size of the anti-thyroid drugs market has seen a slight increase. An expansion is anticipated, from $2.46 billion in 2024 increasing to $2.49 billion in 2025, signifying a compound annual growth rate (CAGR) of 1.2%. The growth during the historical period can be ascribed to the pervasive presence of thyroid conditions, improvements in pharmaceutical development, and advancements in healthcare facilities._x000D_

_x000D_

The market size for anti-thyroid drugs is projected to experience consistent expansion in the upcoming years, reaching $2.76 billion by 2029 with a compound annual growth rate (CAGR) of 2.6%. Anticipated growth during this forecast period is largely tied to factors such as increased patient awareness and education, spendings on healthcare, patient demographics, and worldwide economic conditions. Significant trends for this upcoming period encompass alternatives to thyroid surgery and radioactive iodine, a focus on patient-centered care, as well as developments in telemedicine and remote patient monitoring._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp_x000D_

_x000D_

#Which Factor Is Shaping The Future Of The Research Antibodies and Reagents Market?#_x000D_

The growth of the research antibodies and reagents market is likely to be propelled by escalating investment in medical and health research and development (R&D). In the realm of life science research, these antibodies and reagents play a critical role in exploring biological processes or identifying disease causes through meticulous experiments, observations, lab work, analysis, and tests. For instance, as reported by the National Center for Science and Engineering Statistics (NCSES), a US-based statistical agency, in January 2024, R&D expenditure in the U.S. in 2021 amounted to $789.1 billion. This figure is anticipated to reach $885.6 billion in 2022, showing an increase of $84.1 billion. Therefore, the rising investment in healthcare R&D is set to augment the usage of research antibodies and reagents in the market._x000D_

_x000D_

_x000D_

The anti-thyroid drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)_x000D_

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration_x000D_

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels_x000D_

_x000D_

Subsegments:_x000D_

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil _x000D_

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution_x000D_

_x000D_

#Which Emerging Trends And Strategic Shifts Are Shaping The Research Antibodies and Reagents Market?#_x000D_

Organizations dedicated to thyroid health are taking measures to increase awareness about thyroid disorders, provide information on the latest treatment options, and share findings from various thyroid disorder research. In the United States, about 60% of individuals with hyperthyroidism are unknowingly living with the condition undiagnosed. To tackle these challenges, groups like the American Thyroid Association (ATA) are making strides in educating the public on thyroid conditions. Likewise, the Thyroid Foundation of Canada has embarked on awareness campaigns to raise public consciousness and knowledge on thyroid diseases, including hyperthyroidism. Other associations, such as the American Academy of Otolaryngology and the British Thyroid Foundation, among others, are also initiating awareness efforts and programs._x000D_

_x000D_

#Which Companies Hold The Largest Market Share In The Research Antibodies and Reagents Sector?#_x000D_

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc._x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report_x000D_

_x000D_

#How Does Regional Performance Compare Across The Research Antibodies and Reagents Industry?#_x000D_

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Anti-Thyroid Drugs Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size of anti-thyroid drugs has experienced a slight increase. The predictions place this value to increase from $2.46 billion in 2024, to $2.49 billion in 2025, with a CAGR of 1.2%. Factors contributing to this growth during the historical period include the high occurrence of thyroid disorders, advancements in the development of drugs, and the quality of healthcare infrastructure.

It is projected that the anti-thyroid drugs market will experience consistent growth in the coming years, with its value anticipated to reach $2.76 billion by 2029, increasing at a compound annual growth rate of 2.6%. Elements contributing to this growth throughout the predicted period include increased patient awareness and education, health care spending, demographic factors of patients, and worldwide economic conditions. Key trends predicted for this period encompass alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, as well as the utilization of telemedicine and remote monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

What External and Internal Drivers Are Contributing to the Growth of theAnti-Thyroid Drugs Market?

The prevalence of Graves’ disease, a direct cause of hyperthyroidism, is on the rise. The US-based National Library of Medicine, managed by the federal government, states that in developed nations, Graves’ disease is the primary cause of hyperthyroidism. It typically affects individuals aged between 30 and 60 and is seen 5–10 times more often in women than in men. Genetic factors contribute to about 79% of the risk for this disease, and environmental elements account for the remaining 21%. The growing incidence of Graves’ disease means an increase in the number of hyperthyroidism cases. In turn, this escalates the demand for anti-thyroid medications, thus stimulating market growth.

What Segment Types Define the Anti-Thyroid Drugs Market Structure?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Anti-Thyroid Drugs Market?

Organizations dedicated to thyroid health are putting forth efforts to increase understanding of thyroid diseases, advancements in treatment options, and summaries of various studies about these disorders. In the United States, approximately 60% of hyperthyroidism sufferers are not aware of their condition and go untreated. To address this, organizations such as the American Thyroid Association (ATA) are educating the public about thyroid diseases. In a similar effort, the Thyroid Foundation of Canada is also working to raise public awareness and interest in thyroid disorders, including hyperthyroidism. Other organizations embarking on similar awareness campaigns include the American Academy of Otolaryngology and the British Thyroid Foundation, among others.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

What Is the Definition of the Anti-Thyroid Drugs Market?

Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Anti-Thyroid Drugs Market In 2029?

The market for anti-thyroid drugs has experienced steady growth in the past few years. It is expected to increase from $2.44 billion in 2024 to a value of $2.5 billion in 2025, representing a compound annual growth rate (CAGR) of 2.2%. This growth during the historical period can be traced back to the increasing occurence of thyroid disorders, developments in drug creation and enhancements in healthcare infrastructure.

What Growth Rate Is Forecasted for the Anti-Thyroid Drugs Market by 2029?

Expectations are set for the anti-thyroid drugs market size to experience consistent growth over the next few years. The market is predicted to hit the $2.78 billion mark by 2029, boasting a compound annual growth rate (CAGR) of 2.7%. This anticipated growth in the forecast period can be credited to factors such as patient education and awareness, healthcare expenditure, patient demographics, and the world’s economic conditions. Major advancements projected during this period encompass alternatives to thyroid surgery and radioactive iodine, patient-oriented care, and the rise of telemedicine and remote monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Key Companies Are Shaping the Future of the Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Which Factors Are Driving Demand in the Anti-Thyroid Drugs Industry?

Hyperthyroidism, in numerous instances, is directly associated with Graves’ disease, which is showing a growing prevalence trend. As per the National Library of Medicine, a biomedical library run by the US federal government, Graves’ disease (GD) is the primary cause of hyperthyroidism in developed nations. This disease is predominantly experienced in the age group of 30 to 60, with women proving to be 5–10 times more susceptible than men. The risk of developing GD can largely be attributed to genetic factors, with a 79% likelihood, while environmental elements contribute around 21% to the risk. The tremendous increase in the occurrence of Graves’ disease has led to a rise in hyperthyroidism cases. This leads to a boost in demand for anti-thyroid medications, thereby aiding the market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

How Is the Anti-Thyroid Drugs Market Segmented by Several Divisions?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

What are the Emerging Market Trends Driving the Growth of the Anti-Thyroid Drugs Industry?

Organizations dedicated to thyroid care are initiating measures to expand awareness of thyroid disorders, recent treatment advancements, and various thyroid disorder research findings. In the United States, around 60% of those with hyperthyroidism are unaware of their condition and remain without a diagnosis. The American Thyroid Association (ATA) and other associations are addressing these concerns by raising awareness about thyroid disorders. The Thyroid Foundation of Canada is also taking steps to increase public knowledge and understanding of thyroid diseases, including hyperthyroidism. Among others initiating awareness initiatives and programs are the American Academy of Otolaryngology and the British Thyroid Foundation.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Regions Are Driving Growth in the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

This Report Delivers Insight On:

1. How big is the anti-thyroid drugs market, and how is it changing globally?

2. Who are the major companies in the anti-thyroid drugs market, and how are they performing?

3. What are the key opportunities and risks in the anti-thyroid drugs market right now?

4. Which products or customer segments are growing the most in the anti-thyroid drugs market?

5. What factors are helping or slowing down the growth of the anti-thyroid drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Anti-Thyroid Drugs Market?

Graves’ disease, a primary cause of hyperthyroidism, is also increasing in incidence, further contributing to the demand for anti-thyroid drugs. According to the National Library of Medicine, Graves’ disease is more prevalent in women and typically affects individuals between the ages of 30 and 60. With genetic factors accounting for a large portion of the risk, the growing number of Graves’ disease cases will increase the need for anti-thyroid medications.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

#What is the Projected CAGR for the Anti-Thyroid Drugs Market Size from 2025 to 2034?

The anti-thyroid drugs market has witnessed consistent growth in recent years. It is projected to rise from $2.44 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 2.2%. This growth in the past has been influenced by the widespread presence of thyroid disorders, improvements in pharmaceutical development, and advancements in healthcare infrastructure.

The anti-thyroid drugs market is expected to grow steadily, reaching $2.78 billion by 2029 at a CAGR of 2.7%. The growth is influenced by patient awareness, healthcare expenditure, demographics, and global economic conditions. Major trends include thyroid surgery and radioactive iodine alternatives, patient-centric care, and the adoption of telemedicine and remote monitoring.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

What New Market Trends Are Reshaping theAnti-Thyroid Drugs Market and Its Opportunities?

Organizations focused on thyroid care are ramping up awareness initiatives to address the high rate of undiagnosed thyroid disorders. Associations such as the American Thyroid Association (ATA) and the Thyroid Foundation of Canada are launching educational campaigns to inform the public and improve early detection of conditions like hyperthyroidism.

Who Are the Leading Market Players Fueling Growth in the Anti-Thyroid Drugs Market Trend?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

How is the Global Anti-Thyroid Drugs Market Segemented?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

Which Geographics are Influencing the Growth of the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2025, By The Business Research Company:

Diuretics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito-Urinary Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Drugs for Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the anti-thyroid drugs market grown in recent years?

In recent years, there has been a consistent expansion in the size of the anti-thyroid drugs market. The market, which is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 2.2%. The previous period’s growth can be credited to the widespread incidence of thyroid disorders, advancements in medicine creation, and the development of healthcare structures.

How is the anti-thyroid drugs market size expected to evolve during the forecast period?

The market size for anti-thyroid drugs is forecasted to exhibit solid expansion in the coming years, reaching a value of $2.78 billion in 2029 with a CAGR of 2.7%. This growth during the predicted timeframe can be credited to factors such as increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. Notably, the period is expected to see major trends such as alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, and the adoption of telemedicine and remote monitoring.

Get your anti-thyroid drugs market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which key drivers are propelling the anti-thyroid drugs market’s growth?

The rise in cases of Graves’ disease, which is an immediate cause of hyperthyroidism, has been observed. The US-based National Library of Medicine, owned by the United States federal government, states that Graves’ disease (GD) is the leading cause of hyperthyroidism in developed nations. GD is typically prevalent among those aged between 30 and 60, with women being 5-10 times more vulnerable than men. A 79% genetic predisposition is related to the risk for GD, while 21% is attributable to environmental factors. The rise in Graves’ disease cases is causing an increase in hyperthyroidism sufferers. This has led to a surge in demand for anti-thyroid drugs, thereby propelling the market’s growth.

What are the market segments in the anti-thyroid drugs industry?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which leading companies are shaping the growth of the anti-thyroid drugs market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

What key trends are currently impacting the anti-thyroid drugs market’s development?

Organizations dedicated to thyroid health are stepping up efforts to promote knowledge on thyroid conditions, the latest therapy options, and recent findings in thyroid disorder research. It’s estimated that around 60% of hyperthyroidism sufferers in the USA are undiagnosed and uninformed about their condition. To tackle this problem, several associations such as the American Thyroid Association (ATA) have embarked on educational campaigns about thyroid disorders. Likewise, the Thyroid Foundation of Canada is taking measures to raise public curiosity and consciousness about thyroid diseases, including hyperthyroidism. Other bodies, like the American Academy of Otolaryngology and the British Thyroid Foundation, are implementing awareness and outreach initiatives too.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

Which geographic areas are influencing the growth of the anti-thyroid drugs market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Diuretics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito-Urinary Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Drugs for Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Anti-Thyroid Drugs Market, and What Are the Key Drivers?

In recent years, there has been a consistent expansion in the size of the anti-thyroid drugs market. The market, which is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 2.2%. The previous period’s growth can be credited to the widespread incidence of thyroid disorders, advancements in medicine creation, and the development of healthcare structures.

The market size for anti-thyroid drugs is forecasted to exhibit solid expansion in the coming years, reaching a value of $2.78 billion in 2029 with a CAGR of 2.7%. This growth during the predicted timeframe can be credited to factors such as increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. Notably, the period is expected to see major trends such as alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, and the adoption of telemedicine and remote monitoring.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the Anti-Thyroid Drugs Market?

The rise in cases of Graves’ disease, which is an immediate cause of hyperthyroidism, has been observed. The US-based National Library of Medicine, owned by the United States federal government, states that Graves’ disease (GD) is the leading cause of hyperthyroidism in developed nations. GD is typically prevalent among those aged between 30 and 60, with women being 5-10 times more vulnerable than men. A 79% genetic predisposition is related to the risk for GD, while 21% is attributable to environmental factors. The rise in Graves’ disease cases is causing an increase in hyperthyroidism sufferers. This has led to a surge in demand for anti-thyroid drugs, thereby propelling the market’s growth.

Request Your Free Anti-Thyroid Drugs Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Companies Are Leading the Charge in Expanding the Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

What New Trends Are Reshaping the Anti-Thyroid Drugs Market and Its Opportunities?

Organizations dedicated to thyroid health are stepping up efforts to promote knowledge on thyroid conditions, the latest therapy options, and recent findings in thyroid disorder research. It’s estimated that around 60% of hyperthyroidism sufferers in the USA are undiagnosed and uninformed about their condition. To tackle this problem, several associations such as the American Thyroid Association (ATA) have embarked on educational campaigns about thyroid disorders. Likewise, the Thyroid Foundation of Canada is taking measures to raise public curiosity and consciousness about thyroid diseases, including hyperthyroidism. Other bodies, like the American Academy of Otolaryngology and the British Thyroid Foundation, are implementing awareness and outreach initiatives too.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Key Market Segments Comprise the Anti-Thyroid Drugs Market and Drive Its Revenue Growth?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

What Are the Top Regions Fueling Growth in the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Anti-Thyroid Drugs Market?

Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

Browse Through More Similar Reports By The Business Research Company:

Diuretics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito-Urinary Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Drugs for Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: